Tumor Immune Microenvironment Biomarkers for Recurrence Prediction in Locally Advanced Rectal Cancer Patients after Neoadjuvant Chemoradiotherapy
CD8<sup>+</sup> T cells and AI-powered immune phenotypes, alongside clinical factors, can guide personalized treatment in LARC patients receiving nCRT. A therapeutic strategy to modify the TiME after nCRT could help reduce recurrence after surgery.
Authors
- Taebum Lee (ORCID: https://orcid.org/0000-0002-9472-0644)
- Jun-Eul Hwang
- Hyun-Jin Bang
- Hyeon-Jong Kim (ORCID: https://orcid.org/0000-0003-2722-6520)
- Eun Gene Sun (ORCID: https://orcid.org/0000-0002-3396-6966)
- Chan‐Young Ock (ORCID: https://orcid.org/0000-0002-6755-9728)
- Ik‐Joo Chung (ORCID: https://orcid.org/0000-0003-0479-8067)
- Sung Sun Kim (ORCID: https://orcid.org/0000-0002-8569-2178)
- Jeong‐Seok Nam (ORCID: https://orcid.org/0000-0001-9753-6095)
- Hyun-Jeong Shim (ORCID: https://orcid.org/0000-0001-7450-7822)
- Sang‐Hee Cho (ORCID: https://orcid.org/0000-0002-7995-7862)
- Woo‐Kyun Bae
Institutions
- Gwangju Institute of Science and Technology (KR)
- Chonnam National University Hospital (KR)
- Chonnam National University Hwasun Hospital (KR)
Publication Details
- Journal
- Cancers
- Published
- 2024-09-30
- DOI
- https://doi.org/10.3390/cancers16193353
- Citations
- 3
- Primary Topic
- Colorectal Cancer Surgical Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- Chonnam National University
- Chonnam National University Hwasun Hospital